Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. CBD for hypertension. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 30, 2021

In addition, the company aims to predict what treatments are most effective in addressing these conditions, including psychedelics, which have shown tremendous promise in early clinical trials. Despite the high prevalence of these disorders, few patients are accurately screened and diagnosed. Building the Data Backend.

Treatment 52

Treatment Clinical Trials Research and Development Data 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. CBD for hypertension. Related story Can CBD Help Your Condition?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Guy Goodwin appointed Chief Medical Officer and Danielle Schlosser appointed Senior Vice-President, Clinical Innovation. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE. ” About COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

NORML

SEPTEMBER 20, 2019

Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials. So, that’s one way that they can really sabotage your study outcomes because the study drug is issued to patients by weight.

DEA 230

DEA Research and Development Clinical Trials Patients 230

Otherside Farms

JANUARY 25, 2019

Lead author Dr. Tim England, honorary consultant stroke physician at the University of Nottingham and Royal Derby Hospital, presented the findings at this week’s annual UK Stroke Forum conference. The data are guiding the next steps in experimental stroke in order to be able to progress onto initial safety assessments in a clinical trial.”.

Clinical Trials 74

Clinical Trials Marijuana Cannabinoids Data 74

The Joint Blog

APRIL 21, 2020

For the study researchers with the Nordic Cannabis Research Institute in Denmark reviewed 25 clinical trials assessing the safety and efficacy of CBD in various populations. There is moderate-quality evidence that chronic and acute administration of CBD can improve psychotic symptoms in schizophrenia patients.”

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

NOVEMBER 26, 2021

Corporate and Clinical Development Highlights Include: Completed Patient Enrollment in Phase III Psoriasis Study – The Phase III Comfort™ study completed patient enrollment. dollars in thousands (except for share and per share data). . . Topline results are expected in Q1 2022. Financial Results. 2021. . .

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. Every day is different, (but) at this point I’m at least present,” he said. I never thought that would have been possible,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

The Cannigma

FEBRUARY 11, 2021

One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. That was shocking.”.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

The Joint Blog

NOVEMBER 26, 2019

For the study, researchers at Washington State University analyzed data from 1,959 anonymous marijuana consumers who tracked their marijuana use and headache frequency over a 16-month period. The study, titled Short and Long-term effects of cannabis on headaches and migraine , can be found by clicking here.

Clinical Trials 55

Clinical Trials Research and Development Marijuana Data 55

Cannabis Law Report

JULY 30, 2019

But even if there is no doubt that a regulated market would provide a safer environment for access, we argue that there could be a potential cost to patient safety. From trial to market. Finally, the medicine moves into “efficacy” trials. This is the first time it is given to patients.

Medicine 40

Medicine Clinical Trials Safety Access 40

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

AUGUST 31, 2020

It brings us great pleasure to present the 10 winners of Veriheal’s Innovation in Cannabis Scholarship 2020. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 6, 2021

Dr. Johnson has also been presented with the prestigious Jack Mendelson Award from the NIAAA and the Solomon Carter Fuller Award by the American Psychiatric Association. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” ” About Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

The Cannigma

AUGUST 31, 2021

A 2018 research paper in the International Journal of Drug Policy analyzed in-depth interviews carried out with 24 Israeli physicians working in pain medicine, oncology, and family medicine, and found that “physicians discussed contrasting narratives of cananbi, presenting it as both a medicine and non-medicine.”

Education 101

Education Clinical Trials Medicine Policy 101

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. ” “We found the feedback from both CDRH and CDER to be invaluable as we look to bring our innovative products toward regulatory approval,” said Todd M.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

DECEMBER 7, 2021

Dravet syndrome is a rare presentation of intractable epileptic encephalopathies associated with pleomorphic seizure activity, usually before the one year of age, while Lennox-Gastaut syndrome is characterized by multiple drug-resistant seizure with a unique EEG pattern.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Cannabis Law Report

JANUARY 9, 2019

Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment. Phoenix are conducting short-term CBD oil studies with local patients at the country’s general hospital. It’s important to us to run local trials, so we are not relying on evidence from elsewhere,” Tindall said. “It Photo: Google Maps.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. presented the first official TED Talk about psychedelics. Rick Doblin, Ph.D., and Michael Mithoefer, M.D., Source: [link].

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

CannaTech

SEPTEMBER 16, 2018

These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. It also places limits on a patient’s ability to grow the medicine and possess certain amounts of dried flower. The Need for Cannabis Education Tailored to Patient and Doctor.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

MAY 14, 2022

In addition to the regulatory barriers to access, funding has long been cited as a problem, with limited patient access through the UK’s National Health Service. Canpain is planned to run for three years and aims to conduct clinical trials involving up to 5,000 patients suffering from chronic pain.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

DECEMBER 11, 2021

“More than 40,000 patients have used cannabis to treat their respective illnesses. These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Most are cancer patients.

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome patient pool and forecasted trend for each seven major countries. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken. deletion syndrome is often underdiagnosed and misdiagnosed, as the symptoms vary from patient to patient.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Therapy 52

Cannabis Law Report

AUGUST 18, 2022

As research into the use of psychedelic therapies continues to expand and additional data demonstrate significant positive outcomes in the treatment of mental health conditions, the benefits that psychedelics offer will continue to gain acceptance and understanding across the medical community. ” Joining Ms.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Cannabis Law Report

JANUARY 13, 2020

Justin Gover, GW’s Chief Executive Officer expects to discuss these updates as part of a webcast presentation at the 38 th Annual J.P. EPIDIOLEX commercialization: Continue to drive revenue growth: Build on positive experiences from existing physicians to increase prescribing to appropriate patients. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

OCTOBER 7, 2019

Besides going against all the classic “munchies/stoner” stereotypes, this finding is especially puzzling as cannabis is often used to increase weight gain in patients with medical conditions such as HIV/AIDS and cancer. So why are medical marijuana patients gaining weight when they need to, but losing weight when they don’t?

Marijuana 105

Marijuana Cannabinoids Patients Conditions 105

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Veriheal

MAY 16, 2022

Following the successful experiment into the potential safety and efficacy of using ketamine for Parkinson’s patients, the university proceeded to sign an exclusive licensing partnership with Pharmather Inc. , Studying Ketamine Use for Parkinson’s Disease Patients. As many as 250 clinics across the U.S.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Green Relief

MAY 13, 2018

A 2014 study found that traumatic brain injury ( TBI ) patients who tested positive for THC were more likely to survive with less impairment than TBI patients who abstained from marijuana. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

DECEMBER 21, 2021

The rapid increase in the volume of enterprise data and growing automation of business processes across several end-use industries such as retail, manufacturing, healthcare, and transportation are expected to drive the demand for business software and services over the forecast period. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52